Open AccessCefepime-Induced Encephalopathy in a Tertiary Medical Center in Korea
Author(s) -
Ji Ye Jeon,
Yong Won Cho,
Hye-Jin Moon
Publication year - 2020
Publication title -
journal of clinical neurology/the journal of clinical neurology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.208
H-Index - 45
eISSN - 2005-5013
pISSN - 1738-6586
DOI - 10.3988/jcn.2020.16.3.408
Subject(s) - cefepime , medicine , cephalosporin , encephalopathy , pneumonia , creatinine , gastroenterology , anesthesia , antibiotics , imipenem , chemistry , biochemistry , antibiotic resistance
Cefepime is a widely used fourth-generation cephalosporin. It is commonly used as a first-line antibiotic to treat various infectious diseases such as hospital-acquired pneumonia, urinary tract infections, and bacterial meningitis. The primary outcome of this study was the development of cefepime-induced encephalopathy (CIE) at a tertiary medical center in Korea. We also aimed to describe the clinical features of CIE.